---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-24-000057"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:19:26.017933+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics appoints CEO Robert Connelly as Principal Financial and Accounting Officer

## Summary
- Robert Connelly, already CEO and President, appointed as Principal Accounting Officer and Principal Financial Officer effective Oct 15, 2024.
- Connelly has nearly 40 years of life science leadership; previously CEO of Axcella Health, Pulmatrix, and Domantis (acquired by GSK).
- No family relationships with other directors or executive officers; no reportable transactions under Item 404(a).

## SEC filing metadata
- accession: 0001601485-24-000057
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/0001601485-24-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/angn-20241015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-24-000057
- JSON: https://secwatch.observer/filing/0001601485-24-000057.json
- Plain text: https://secwatch.observer/filing/0001601485-24-000057.txt

## Key facts
- Executive change
  Robert Connelly was appointed as Principal Accounting Officer and Principal Financial Officer at Elicio Therapeutics, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer and Principal Financial Officer
  source text: On October 15, 2024 , Elicio Therapeutics, Inc. (the “Company”) appointed Robert Connelly as the Company’s Principal Accounting Officer and Principal Financial Officer effective October 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/0001601485-24-000057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.